# Understanding Frailty in IBD: Implications for Clinical Outcomes and Multidisciplinary Care

**Authors:** Silvia Salvatori, Irene Marafini, Giovanni Monteleone

PMC · DOI: 10.3390/jcm15041440 · Journal of Clinical Medicine · 2026-02-12

## TL;DR

This paper explores how frailty affects inflammatory bowel disease patients and highlights the need for early detection and multidisciplinary care to improve outcomes.

## Contribution

The paper provides a comprehensive review of frailty in IBD, emphasizing its causes, evaluation, and treatment strategies.

## Key findings

- Frailty in IBD is linked to ongoing inflammation and predicts negative health outcomes like hospitalization and mortality.
- Frailty in IBD patients is often under-recognized in standard clinical practice despite available assessment tools.
- A multidisciplinary approach is needed to manage frailty in IBD, focusing on disease control, nutrition, and comorbidities.

## Abstract

Frailty is a complex syndrome characterized by a gradual decline in physical ability and a higher sensitivity to external stress. While it has traditionally been linked to aging, frailty is increasingly seen as an important factor affecting the health of patients with inflammatory bowel disease (IBD). IBD mainly affects the gastrointestinal tract but is often associated with systemic manifestations, such as extra-intestinal symptoms/signs, malnutrition, muscle loss, and other health problems, all of which could contribute to frailty. There are various tools to assess frailty in IBD patients, even though it is often not recognized or evaluated well in standard clinical practice. Recent evidence indicates that frailty in IBD may be partly driven by ongoing inflammation and is an independent predictor of negative health outcomes (e.g., hospitalization rates, surgical complications, and mortality). Proper management of frailty in IBD needs a broad, team-based approach that focuses on controlling disease symptoms, improving nutrition, physical abilities, and managing other comorbidities. This review aims to give a clear overview of the causes, clinical evaluation, and treatment options for frailty in IBD, emphasizing the need for early detection and intervention.

## Linked entities

- **Diseases:** inflammatory bowel disease (MONDO:0005265)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, SMAD7 (SMAD family member 7) [NCBI Gene 4092] {aka CRCS3, MADH7, MADH8}
- **Diseases:** malabsorption (MESH:D008286), malnutrition (MESH:D044342), death (MESH:D003643), muscle catabolism (MESH:D019042), growth retardation (MESH:D006130), injury to (MESH:D014947), Chronic systemic inflammation (MESH:D007249), gastrointestinal symptoms (MESH:D012817), Clavien class IV complications (MESH:D008107), sarcopenia (MESH:D055948), fibrosis (MESH:D005355), wound infections (MESH:D014946), cardiopulmonary complications (MESH:D006323), anastomotic leaks (MESH:D057868), weight loss (MESH:D015431), toxicity (MESH:D064420), osteoporosis (MESH:D010024), anxiety (MESH:D001007), CD (MESH:D003424), Reduced hepatic and renal function (MESH:D001523), infection (MESH:D007239), diabetes (MESH:D003920), cancer (MESH:D009369), functional deficits (MESH:D001289), fatigue (MESH:D005221), loss of muscle mass and function (MESH:D009135), hypersensitivity (MESH:D004342), heart disease (MESH:D006331), mood disorders (MESH:D019964), IBD (MESH:D015212), depression (MESH:D003866), Cognitive deficits (MESH:D003072), loss of muscle mass (MESH:C536030), UC (MESH:D003093), Clinical Frailty (MESH:D000073496), impaired memory and concentration (MESH:D008569), geriatric deficits (MESH:D009461), healing (MESH:C563468), septic (MESH:D001170)
- **Chemicals:** zinc (MESH:D015032), vitamin D (MESH:D014807), iron (MESH:D007501), B12 (MESH:C034730), Steroid (MESH:D013256), oligonucleotides (MESH:D009841)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942479/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942479/full.md

## References

70 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942479/full.md

---
Source: https://tomesphere.com/paper/PMC12942479